Longboard Pharmaceuticals, Inc.
LBPHDelisted Dec 2, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001832168
Longboard Pharmaceuticals, Inc. was delisted on Dec 2, 2024; its insiders filed their last Form 4 on Dec 2, 2024; 125 institutions reported holding it in 13F filings for Q3 2024, worth $1.33B in total; Viking Global Investors was the only superinvestor holding it.
13F holders, Q3 2024
Institutional positions in Longboard Pharmaceuticals, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
LBPH is no longer listed, so this page shows Q3 2024. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 125
- +26 vs. Q2 2024
- Shares held
- 39.8M
- +3.37M (+9.3%) vs. Q2 2024
- Total value
- $1.33B
- +$341.9M (+34.7%) vs. Q2 2024
- New holders
- 36
- 53 more added
- Sold out
- 10
- 28 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LBPH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 125 | $1.33B |
| Q2 2024 | 100 | $1.05B |
| Q1 2024 | 105 | $819.5M |
| Q4 2023 | 52 | $99.7M |
| Q3 2023 | 51 | $87.1M |
| Q2 2023 | 50 | $106.7M |
| Q1 2023 | 25 | $51.5M |
| Q4 2022 | 18 | $23.3M |
| Q3 2022 | 19 | $27.0M |
| Q2 2022 | 20 | $23.3M |
| Q1 2022 | 21 | $40.1M |
| Q4 2021 | 21 | $37.8M |
| Q3 2021 | 20 | $68.2M |
| Q2 2021 | 17 | $71.7M |
| Q1 2021 | 22 | $142.8M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Longboard Pharmaceuticals, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 375,256 | $12.5M | 0.00% | +296,611+377.2% | Added |
| Emerald Mutual Fund Advisers Trust | 419,462 | $14.0M | 0.73% | +235,885+128.5% | Added |
| Parkman Healthcare Partners LLC | 491,272 | $16.4M | 2.09% | −202,906−29.2% | Reduced |
| Marshall Wace, LLP | 507,781 | $16.9M | 0.02% | +45,158+9.8% | Added |
| American Century Companies Inc | 569,738 | $19.0M | 0.01% | +93,348+19.6% | Added |
| Lord, Abbett & Co. LLC | 626,905 | $20.9M | 0.07% | +164,795+35.7% | Added |
| Emerald Advisers, LLC | 683,642 | $22.8M | 0.88% | +455,119+199.2% | Added |
| Driehaus Capital Management LLC | 729,549 | $24.3M | 0.21% | +240,756+49.3% | Added |
| Geode Capital Management, LLC | 746,147 | $24.9M | 0.00% | +63,756+9.3% | Added |
| State Street Corp | 855,814 | $28.5M | 0.00% | +53,962+6.7% | Added |
| Siren, L.L.C. | 903,227 | $30.1M | 1.51% | +903,227 | New |
| Jennison Associates LLC | 917,528 | $30.6M | 0.02% | −34,440−3.6% | Reduced |
| Pictet Asset Management Holding SA | 918,573 | $30.6M | 0.03% | +4,791+0.5% | Added |
| Woodline Partners LP | 1,004,705 | $33.5M | 0.28% | +940,267+1,459.2% | Added |
| Goldman Sachs Group Inc | 1,026,703 | $34.2M | 0.01% | +701,760+216.0% | Added |
| Integral Health Asset Management, LLC | 1,050,000 | $35.0M | 4.12% | −50,000−4.5% | Reduced |
| Polar Capital Holdings Plc | 1,102,740 | $36.8M | 0.22% | −251,765−18.6% | Reduced |
| Wellington Management Group LLP | 1,590,072 | $53.0M | 0.01% | −188,899−10.6% | Reduced |
| Viking Global Investors LPSuperinvestorViking Global Investors | 1,969,041 | $65.6M | 0.24% | +310,079+18.7% | Added |
| Vanguard Group Inc | 2,033,068 | $67.8M | 0.00% | +107,921+5.6% | Added |
| Cormorant Asset Management, LP | 2,790,462 | $93.0M | 4.93% | 00.0% | Unchanged |
| BlackRock, Inc. | 2,837,880 | $94.6M | 0.00% | +2,837,880 | New |
| Price T Rowe Associates Inc | 2,909,257 | $97.0M | 0.01% | +400,721+16.0% | Added |
| Farallon Capital Management, L.L.C. | 3,150,857 | $105.0M | 0.58% | +210,357+7.2% | Added |
| FMR LLC | 4,350,099 | $145.0M | 0.01% | −65,119−1.5% | Reduced |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −3,289,119−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −1,031,371−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −212,879−100.0% | Sold out |
| Braidwell LP | 0 | $0 | 0.00% | −205,926−100.0% | Sold out |
| Lynx1 Capital Management LP | 0 | $0 | 0.00% | −167,317−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −80,514−100.0% | Sold out |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −66,149−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −21,242−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −8,032−100.0% | Sold out |
| Shay Capital LLC | 0 | $0 | 0.00% | −7,500−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |